drugset / Trial / NCT00849459
Gene Therapy in Treating Women With Metastatic Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Placing the gene for interleukin-12 into breast cancer cells may help the body build an immune response to kill tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of gene therapy in treating women with metastatic breast cancer.
Timeline
- Start
- 2008-08
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | adenovirus-mediated human interleukin-12 | Unknown | 1e+10 unknown | Other |
| Subject | adenovirus-mediated human interleukin-12 | Unknown | 1e+13 unknown | Other |
| Subject | adenovirus-mediated human interleukin-12 | Unknown | 2e+13 unknown | Other |
| Subject | adenovirus-mediated human interleukin-12 | Unknown | 3e+13 unknown | Other |